Glympse Bio hopes to go straight to the source to better diagnose diseases by using a new class of traveling artificial nanosensors that directly query the body’s disease before reporting back to us on the outside.
These are the ideas that can move the needle. FierceMedTech’s Fierce 15 class of 2018 is aimed at advancement—whether it’s simply combining new know-how with old methods, making definitive improvements in well-trodden fields, or pushing us to reconsider how far we can reach with the means available today.
